HomeANTX • NASDAQ
add
AN2 Therapeutics Inc
Previous close
$1.36
Day range
$1.33 - $1.40
Year range
$0.87 - $3.88
Market cap
41.84M USD
Avg Volume
131.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.61M | -54.25% |
Net income | -7.52M | 55.49% |
Net profit margin | — | — |
Earnings per share | -0.25 | 55.79% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 83.62M | -22.07% |
Total assets | 92.09M | -33.63% |
Total liabilities | 10.24M | -27.10% |
Total equity | 81.85M | — |
Shares outstanding | 30.10M | — |
Price to book | 0.50 | — |
Return on assets | -22.68% | — |
Return on capital | -25.39% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -7.52M | 55.49% |
Cash from operations | -5.27M | 69.11% |
Cash from investing | -6.88M | -1,738.10% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -12.15M | 28.38% |
Free cash flow | -10.10M | 7.74% |
About
Founded
2017
Headquarters
Website
Employees
22
